In my role leading clinical market development, I managed a team of nine professionals and implemented a dual-pronged strategy to shift market dynamics. This approach combined top-down initiatives—such as cultivating key opinion leader (KOL) relationships and enhancing visibility within clinical societies—with grassroots efforts focused on localized engagement and field-level influence.